New epigenetic drug strategy to treat cancer
Thursday, October 25, 2018 - 17:40
in Health & Medicine
Researchers have discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer. Reactivation leads to restored tumor suppressor gene expression and enhanced anti-cancer immunity.